ALDH2 and cancer: This substantial reduction in ALDH2 activity in ALDH2*2 carriers compromises aldehyde detoxification, increasing susceptibility to aldehyde-related health risks such as upper aerodigestive tract (UADT) cancer and cardiovascular disease [30,32,33].